资讯

U.S. Conjunctivitis Treatment Market to Hit USD 2.14 Billion by 2032 Amid Increased OTC Drug Adoption, Allergy Incidences, and Telehealth Growth.Austin, July 15, 2025 (GLOBE NEWSWIRE) -- ...
Key drivers include increasing adult cases and a shift towards immunomodulatory therapies like Cyclosporine A. Expansion in allergy clinics and strat ...